amiodarone has been researched along with Lung Diseases, Interstitial in 64 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of the study was to assess the diagnostic accuracy of pCLE for amiodarone-related pneumonia (AMR-IP)." | 9.17 | In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia. ( Bergot, E; Bourg-Heckly, G; Dominique, S; Genevois, A; Jounieaux, V; Roussel, F; Salaün, M; Thiberville, L; Vergnon, JM; Vever-Bizet, C; Zalcman, G, 2013) |
| "Although oral amiodarone (AMD) has been used for the management of atrial fibrillation (AF), serious complications such as interstitial pneumonia (IP) occur very occasionally." | 7.83 | Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients. ( Fujino, T; Fukunaga, S; Ikeda, T; Kinoshita, T; Kitahara, K; Kobayashi, K; Koike, H; Koike, M; Sato, H; Shinohara, M; Suzuki, T; Yuzawa, H, 2016) |
| "Amiodarone use has been rarely associated with the development of acute respiratory distress syndrome (ARDS), usually in association with surgery or pulmonary angiography." | 7.78 | Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure. ( Bangalore, S; Grosu, H; Jean, R; Kumar, S; Kumari, R, 2012) |
| "Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil." | 7.73 | [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006) |
| "Amiodarone is a widely used antiarrhythmic agent for supraventricular and ventricular tachyarrhythmias." | 5.46 | Amiodarone Induced Interstitial and Organizing Pneumonia Reversed with Steroids. ( Chatterjee, K; Khasawneh, K; Kuriakose, K; Paydak, H; Rochlani, YM, 2017) |
| "Amiodarone is a highly effective antiarrhythmic agent used in life-threatening ventricular and supraventricular arrhythmias." | 5.35 | Amiodarone induced pneumonitis and hyperthyroidism: case report. ( Ambroziak, U; Bareła, AD; Chazan, R; Grabczak, EM; Opuchlik, A; Potulska, A; Wiwała, J; Zielonka, TM, 2008) |
| " The objective of the study was to assess the diagnostic accuracy of pCLE for amiodarone-related pneumonia (AMR-IP)." | 5.17 | In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia. ( Bergot, E; Bourg-Heckly, G; Dominique, S; Genevois, A; Jounieaux, V; Roussel, F; Salaün, M; Thiberville, L; Vergnon, JM; Vever-Bizet, C; Zalcman, G, 2013) |
| "Although oral amiodarone (AMD) has been used for the management of atrial fibrillation (AF), serious complications such as interstitial pneumonia (IP) occur very occasionally." | 3.83 | Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients. ( Fujino, T; Fukunaga, S; Ikeda, T; Kinoshita, T; Kitahara, K; Kobayashi, K; Koike, H; Koike, M; Sato, H; Shinohara, M; Suzuki, T; Yuzawa, H, 2016) |
| "Amiodarone use has been rarely associated with the development of acute respiratory distress syndrome (ARDS), usually in association with surgery or pulmonary angiography." | 3.78 | Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure. ( Bangalore, S; Grosu, H; Jean, R; Kumar, S; Kumari, R, 2012) |
| "Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil." | 3.73 | [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006) |
| "We report amiodarone-induced pulmonary toxicity in an 18-year-old boy who had undergone corrective surgery for tetralogy of Fallot 4 years earlier, and was treated with amiodarone because of recurrent malignant postoperative ventricular tachyarrhythmias." | 3.70 | Amiodarone-induced pulmonary toxicity in an adolescent. ( Balijepally, S; Kothari, SS; Taneja, K, 1999) |
| " Cells were obtained from patients with idiopathic pulmonary fibrosis (n = 10), patients with sarcoidosis (n = 20), and patients receiving amiodarone without evidence of clinical lung disease (n = 10) as well as from normal volunteers (n = 8)." | 3.68 | Alveolar macrophage surface carbohydrate expression is altered in interstitial lung disease as determined by lectin-binding profiles. ( Auerbach, R; Meyer, KC; Powers, C; Rosenthal, N, 1993) |
| "Drug-induced interstitial lung disease has been reported as a severe adverse effect of some drugs, such as bleomycin, amiodarone, and methotrexate." | 2.82 | Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics. ( Li, S; Shi, J; Tang, H, 2022) |
| "Four patients with interstitial lung disease who were treated by amiodarone for ischemic heart diseases were evaluated by a conventional clinical workup." | 2.73 | The role of induced sputum in amiodarone-associated interstitial lung diseases. ( Fireman, E; Priel, IE; Topilsky, I; Viskin, S, 2007) |
| "Amiodarone is a drug commonly used to treat and prevent cardiac arrhythmias, but it is often associated with several adverse effects, the most serious of which is pulmonary toxicity." | 2.72 | A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone-induced interstitial pneumonia. ( Aspromonte, N; Cappannoli, L; Crea, F; Massetti, M; Petrolati, E; Rabini, A; Scacciavillani, R; Smargiassi, A; Telesca, A, 2021) |
| "Diagnosis of extrinsic allergic alveolitis is based on the association of clinical, radiological, functional, immunological criteria and bronchoalveolar lavage fluid analysis." | 2.41 | [Diffuse infiltrative lung diseases due to allergy and iatrogenic causes]. ( Dalphin, JC, 2000) |
| " The most serious adverse reaction is pulmonary toxicity." | 2.40 | [Amiodarone-induced pulmonary toxicity]. ( Berg, M; Heisel, A; Schieffer, H; Stopp, M; Ukena, D, 1997) |
| "Amiodarone is an antiarrhythmic agent that is used commonly in clinical practice." | 1.51 | Amiodarone-induced diffuse alveolar haemorrhage: a rare but potentially life-threatening complication of a commonly prescribed medication. ( Abdullah, HMA; Khan, UI; Saeed, J; Waqas, QA, 2019) |
| "Amiodarone is a widely used antiarrhythmic agent for supraventricular and ventricular tachyarrhythmias." | 1.46 | Amiodarone Induced Interstitial and Organizing Pneumonia Reversed with Steroids. ( Chatterjee, K; Khasawneh, K; Kuriakose, K; Paydak, H; Rochlani, YM, 2017) |
| "Amiodarone is a highly effective antiarrhythmic agent." | 1.42 | ECMO for pulmonary rescue in an adult with amiodarone-induced toxicity. ( Benassi, F; Meli, M; Molardi, A; Righi, E; Santangelo, R, 2015) |
| "Dronedarone is an amiodarone-like antiarrhythmic with a modified structure." | 1.42 | Diffuse alveolar damage in a patient receiving dronedarone. ( Ahuja, N; Casto, A; Nguyen, DV; Stack, S, 2015) |
| "Idiopathic pulmonary fibrosis (IPF), the most common and lethal of the idiopathic interstitial pneumonias, is defined by a radiological and/or pathological pattern of usual interstitial pneumonia (UIP)." | 1.40 | Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic? ( Bonella, F; Cavazza, A; Rossi, G; Spagnolo, P; Sverzellati, N; Wuyts, WA, 2014) |
| " Due to a very long half-life, accumulation can only be prevented by strict adherence to certain dosage patterns." | 1.39 | Amiodarone-induced pulmonary toxicity--a fatal case report and literature review. ( Breithardt, G; Buerke, B; Hilker, E; Lebiedz, P; Range, FT, 2013) |
| "Amiodarone is a highly effective antiarrhythmic agent used in life-threatening ventricular and supraventricular arrhythmias." | 1.35 | Amiodarone induced pneumonitis and hyperthyroidism: case report. ( Ambroziak, U; Bareła, AD; Chazan, R; Grabczak, EM; Opuchlik, A; Potulska, A; Wiwała, J; Zielonka, TM, 2008) |
| "Phase I of this study involved compilation of a database of adverse reactions to amiodarone reported to the Australian and US drug agencies, and identification of risk factors for AIPT using logistic regression analysis." | 1.35 | Amiodarone-induced pulmonary toxicity. ( Ernawati, DK; Hughes, JD; Stafford, L, 2008) |
| "We present a patient with COPD, in whom interstitial pneumonitis with radiologic features of organizing pneumonia developed after one year of amiodaron treatment due to supraventricular and ventricular arrhythmias." | 1.35 | [Interstitial pneumonitis in a patient treated with amiodarone -- case report]. ( Burakowska, B; Fijałkowska, A; Paczek, A; Szturmowicz, M; Torbicki, A; Wiatr, E, 2008) |
| "The diagnosis was interstitial pneumonitis induced by amiodarone." | 1.33 | [Interstitial pneumonitis followed by syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy for dilated cardiomyopathy: a case report]. ( Arakawa, T; Hashimoto, Y; Ichihara, N; Isobe, M; Matsumura, A; Sato, S; Suzuki, M; Yoshikawa, S, 2006) |
| "Amiodarone-induced lung injury has characteristic pathologic features which may provide clues to diagnosis." | 1.33 | [Clinicopathologic manifestation of amiodarone-induced lung injury]. ( Liu, HR; Shi, JH; Xu, WB; Zhu, YJ, 2006) |
| "Amiodarone treatment was terminated, and the patient was given corticosteroids." | 1.33 | Amiodarone pulmonary toxicity: a patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse. ( Kobayashi, N; Kojima, J; Kudo, K; Okayasu, K; Sugiyama, H; Takeda, Y; Yoshizawa, A, 2006) |
| "AIPT-I had interstitial pneumonitis (n=4) and AIPT-II had interstitial pneumonitis with fibrosis (n=5)." | 1.32 | Value of technetium-99m diethyltriamine pentaaceticacid radioaerosol inhalation lung scintigraphy for the stage of amiodarone-induced pulmonary toxicity. ( Altaner, S; Altun, A; Berkada, S; Durmus-Altun, G; Ozbay, G; Sami Salihoglu, Y, 2004) |
| "Amiodarone is a useful drug for the treatment of life-threatening cardiac arrhythmias." | 1.31 | Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity. ( Kawahara, Y; Matsushima, T; Miyashita, N; Nakajima, M; Niki, Y; Yoshida, K, 2000) |
| "Amiodarone is an antiarrhythmic drug that can cause interstitial pneumonitis leading to pulmonary fibrosis." | 1.31 | HRCT findings of amiodarone pulmonary toxicity: clinical and radiologic regression. ( Heering, P; Hetzel, G; Koch, JA; May, P; Mödder, U; Poll, LW, 2001) |
| "Amiodarone is an effective class-III antiarrhythmic agent." | 1.30 | [Spontaneous remission of an amiodarone-induced pulmonary lesion]. ( Müller, M; Schima, W; Weissel, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (20.31) | 18.2507 |
| 2000's | 29 (45.31) | 29.6817 |
| 2010's | 19 (29.69) | 24.3611 |
| 2020's | 3 (4.69) | 2.80 |
| Authors | Studies |
|---|---|
| Li, S | 1 |
| Shi, J | 1 |
| Tang, H | 1 |
| Saeed, J | 1 |
| Waqas, QA | 1 |
| Khan, UI | 1 |
| Abdullah, HMA | 1 |
| Kinoshita, S | 1 |
| Hosomi, K | 1 |
| Yokoyama, S | 1 |
| Takada, M | 1 |
| Cappannoli, L | 1 |
| Telesca, A | 1 |
| Scacciavillani, R | 1 |
| Petrolati, E | 1 |
| Smargiassi, A | 1 |
| Rabini, A | 1 |
| Massetti, M | 1 |
| Crea, F | 1 |
| Aspromonte, N | 1 |
| Voruganti, DC | 1 |
| Cadaret, L | 1 |
| Kaya, SB | 1 |
| Deger, S | 1 |
| Hacievliyagil, SS | 1 |
| Aytemur, ZA | 1 |
| Roden, AC | 1 |
| Camus, P | 1 |
| Chatterjee, K | 1 |
| Rochlani, YM | 1 |
| Kuriakose, K | 1 |
| Khasawneh, K | 1 |
| Paydak, H | 1 |
| Kubo, K | 1 |
| Azuma, A | 1 |
| Kanazawa, M | 1 |
| Kameda, H | 1 |
| Kusumoto, M | 1 |
| Genma, A | 1 |
| Saijo, Y | 1 |
| Sakai, F | 1 |
| Sugiyama, Y | 1 |
| Tatsumi, K | 1 |
| Dohi, M | 1 |
| Tokuda, H | 1 |
| Hashimoto, S | 1 |
| Hattori, N | 1 |
| Hanaoka, M | 1 |
| Fukuda, Y | 1 |
| Benassi, F | 1 |
| Molardi, A | 1 |
| Righi, E | 1 |
| Santangelo, R | 1 |
| Meli, M | 1 |
| Wuyts, WA | 1 |
| Cavazza, A | 1 |
| Rossi, G | 1 |
| Bonella, F | 1 |
| Sverzellati, N | 1 |
| Spagnolo, P | 1 |
| Stack, S | 1 |
| Nguyen, DV | 1 |
| Casto, A | 1 |
| Ahuja, N | 1 |
| Scheschkowski, T | 1 |
| Budweiser, S | 1 |
| Koike, H | 1 |
| Fujino, T | 1 |
| Koike, M | 1 |
| Shinohara, M | 1 |
| Kitahara, K | 1 |
| Kinoshita, T | 1 |
| Yuzawa, H | 1 |
| Suzuki, T | 1 |
| Sato, H | 1 |
| Fukunaga, S | 1 |
| Kobayashi, K | 1 |
| Ikeda, T | 1 |
| Hori, Y | 1 |
| Nakahara, S | 1 |
| Mine, S | 1 |
| Anjo, N | 1 |
| Fujii, A | 1 |
| Ueda, Y | 1 |
| Taguchi, I | 1 |
| Grabczak, EM | 1 |
| Zielonka, TM | 1 |
| Wiwała, J | 1 |
| Bareła, AD | 1 |
| Opuchlik, A | 1 |
| Potulska, A | 1 |
| Ambroziak, U | 1 |
| Chazan, R | 1 |
| Lehmann, LH | 1 |
| Weichert, W | 1 |
| Schnapauff, D | 1 |
| Dietz, R | 1 |
| Stockburger, M | 1 |
| Heisel, A | 1 |
| Berg, M | 1 |
| Stopp, M | 1 |
| Ukena, D | 1 |
| Schieffer, H | 1 |
| Shimada, YJ | 1 |
| Sato, K | 1 |
| Hanon, S | 1 |
| Schweitzer, P | 1 |
| Freise, J | 1 |
| Wehmeier, P | 1 |
| Welte, T | 1 |
| Tanawuttiwat, T | 1 |
| Harindhanavudhi, T | 1 |
| Hanif, S | 1 |
| Sahloul, MZ | 1 |
| Kumar, S | 1 |
| Bangalore, S | 1 |
| Kumari, R | 1 |
| Grosu, H | 1 |
| Jean, R | 1 |
| Jackevicius, CA | 1 |
| Tom, A | 1 |
| Essebag, V | 1 |
| Eisenberg, MJ | 1 |
| Rahme, E | 1 |
| Tu, JV | 1 |
| Humphries, K | 1 |
| Behlouli, H | 1 |
| Pilote, L | 1 |
| Hernández Voth, AR | 1 |
| Catalán, JS | 1 |
| Benavides Mañas, PD | 1 |
| Avila Martínez, RJ | 1 |
| Peñalver Paolini, CL | 1 |
| Díaz de Atauri Rodríguez, MJ | 1 |
| Salaün, M | 1 |
| Roussel, F | 1 |
| Bourg-Heckly, G | 1 |
| Vever-Bizet, C | 1 |
| Dominique, S | 1 |
| Genevois, A | 1 |
| Jounieaux, V | 1 |
| Zalcman, G | 1 |
| Bergot, E | 1 |
| Vergnon, JM | 1 |
| Thiberville, L | 1 |
| Range, FT | 1 |
| Hilker, E | 1 |
| Breithardt, G | 1 |
| Buerke, B | 1 |
| Lebiedz, P | 1 |
| Umetani, K | 1 |
| Abe, M | 1 |
| Kawabata, K | 1 |
| Iida, T | 1 |
| Kohno, I | 1 |
| Sawanobori, T | 1 |
| Kugiyama, K | 1 |
| Malhotra, A | 1 |
| Muse, VV | 1 |
| Mark, EJ | 1 |
| Durmus-Altun, G | 1 |
| Altun, A | 1 |
| Sami Salihoglu, Y | 1 |
| Altaner, S | 1 |
| Berkada, S | 1 |
| Ozbay, G | 1 |
| Omeroglu, G | 1 |
| Kalugina, Y | 1 |
| Ersahin, C | 1 |
| Wojcik, EM | 1 |
| Itoh, Y | 1 |
| Sendo, T | 1 |
| Oishi, R | 1 |
| Yoshikawa, S | 1 |
| Suzuki, M | 1 |
| Ichihara, N | 1 |
| Sato, S | 1 |
| Arakawa, T | 1 |
| Matsumura, A | 1 |
| Hashimoto, Y | 1 |
| Isobe, M | 1 |
| Shi, JH | 1 |
| Liu, HR | 1 |
| Zhu, YJ | 1 |
| Xu, WB | 1 |
| Fireman, E | 1 |
| Topilsky, I | 1 |
| Viskin, S | 1 |
| Priel, IE | 1 |
| Okayasu, K | 1 |
| Takeda, Y | 1 |
| Kojima, J | 1 |
| Yoshizawa, A | 1 |
| Kobayashi, N | 1 |
| Sugiyama, H | 1 |
| Kudo, K | 1 |
| Kimura, M | 1 |
| Ogawa, H | 1 |
| Wakeyama, T | 1 |
| Takaki, A | 1 |
| Iwami, T | 1 |
| Hadano, Y | 1 |
| Miyazaki, Y | 1 |
| Shimizu, A | 1 |
| Matsuzaki, M | 1 |
| Rayner, B | 1 |
| Golomb, BA | 1 |
| Evans, MA | 1 |
| Tsukada, YT | 1 |
| Kishida, H | 1 |
| Emby, DJ | 1 |
| Ernawati, DK | 1 |
| Stafford, L | 1 |
| Hughes, JD | 1 |
| Paczek, A | 1 |
| Szturmowicz, M | 1 |
| Wiatr, E | 1 |
| Burakowska, B | 1 |
| Fijałkowska, A | 1 |
| Torbicki, A | 1 |
| Pitton, MB | 1 |
| Schweden, F | 1 |
| Lenci, G | 1 |
| Ansoborlo, P | 1 |
| Constans, J | 1 |
| Le Métayer, P | 1 |
| Conri, C | 1 |
| Mathru, M | 1 |
| McDaniel, LB | 1 |
| Meyer, KC | 1 |
| Powers, C | 1 |
| Rosenthal, N | 1 |
| Auerbach, R | 1 |
| Vizioli, LD | 1 |
| Cho, S | 1 |
| Carvalho, CR | 1 |
| Kairalla, RA | 1 |
| Capelozzi, VL | 1 |
| Amato, MB | 1 |
| Saldiva, PH | 1 |
| Villain, E | 1 |
| Müller, M | 1 |
| Schima, W | 1 |
| Weissel, M | 1 |
| de Granda Orive, JI | 1 |
| Herrera de la Rosa, A | 1 |
| Martínez Albiach, JM | 1 |
| Escobar Sacristán, JA | 1 |
| Sáez Valls, R | 1 |
| Gallego Rodríguez, V | 1 |
| Kothari, SS | 1 |
| Balijepally, S | 1 |
| Taneja, K | 1 |
| Cockcroft, DW | 1 |
| Fisher, KL | 1 |
| Wilhelm, JM | 1 |
| Thannberger, P | 1 |
| Derragui, A | 1 |
| Ruxer, S | 1 |
| Saraceni, O | 1 |
| Kieffer, P | 1 |
| Endoh, Y | 2 |
| Hanai, R | 2 |
| Uto, K | 2 |
| Uno, M | 1 |
| Nagashima, H | 1 |
| Narimatsu, A | 1 |
| Takizawa, T | 1 |
| Onishi, S | 1 |
| Kasanuki, H | 2 |
| Tanaka, T | 1 |
| Ohta, Y | 1 |
| Ohnishi, S | 1 |
| Dalphin, JC | 1 |
| Kohno, N | 1 |
| Yokoyama, A | 1 |
| Kondo, K | 1 |
| Nakajima, M | 1 |
| Kawahara, Y | 1 |
| Yoshida, K | 1 |
| Miyashita, N | 1 |
| Niki, Y | 1 |
| Matsushima, T | 1 |
| Stiefelhagen, P | 1 |
| Bhagat, R | 1 |
| Sporn, TA | 1 |
| Long, GD | 1 |
| Folz, RJ | 1 |
| Poll, LW | 1 |
| May, P | 1 |
| Koch, JA | 1 |
| Hetzel, G | 1 |
| Heering, P | 1 |
| Mödder, U | 1 |
| Trzpuc, TD | 1 |
| Shidham, VB | 1 |
| Rao, RN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Endoscopic Follow-up of Low Grade Precancerous Bronchial Lesions in High Risk Patients (SELEPREBB1)[NCT00213603] | 365 participants (Actual) | Observational | 2002-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for amiodarone and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics.
Topics: Amiodarone; Animals; Bleomycin; Disease Models, Animal; Idiopathic Pulmonary Fibrosis; Lung; Lung Di | 2022 |
A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone-induced interstitial pneumonia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; COVID-19; Diagnosis, Differential; Humans; Lung Diseases, | 2021 |
Iatrogenic pulmonary lesions.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Drug-Related Side Effects and Adverse Rea | 2018 |
[Amiodarone-induced pulmonary toxicity].
Topics: Amiodarone; Anti-Arrhythmia Agents; Bronchial Spasm; Controlled Clinical Trials as Topic; Cryptogeni | 1997 |
[Drug-induced lung diseases].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Ant | 2006 |
[Adverse effects of cardiovascular agents].
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Brugada Syndrome; Drug Interactions; Fibrinolyti | 2007 |
[Diffuse infiltrative lung diseases due to allergy and iatrogenic causes].
Topics: Alveolitis, Extrinsic Allergic; Amiodarone; Anti-Arrhythmia Agents; Bronchoalveolar Lavage Fluid; Cr | 2000 |
3 trials available for amiodarone and Lung Diseases, Interstitial
| Article | Year |
|---|---|
In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia.
Topics: Aged; Aged, 80 and over; Amiodarone; Bronchoalveolar Lavage; Bronchoscopy; Female; Fluorescent Dyes; | 2013 |
The role of induced sputum in amiodarone-associated interstitial lung diseases.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Lung Diseases, Interstitial; Male; Myocard | 2007 |
Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity.
Topics: Adult; Aged; Amiodarone; Antigens; Antigens, Neoplasm; Atrial Fibrillation; Biomarkers; C-Reactive P | 2000 |
54 other studies available for amiodarone and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Amiodarone-induced diffuse alveolar haemorrhage: a rare but potentially life-threatening complication of a commonly prescribed medication.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Female; Hemorrhage; Humans; Lung | 2019 |
Inverse Association between Metformin and Amiodarone-Associated Extracardiac Adverse Events.
Topics: Adverse Drug Reaction Reporting Systems; Amiodarone; Humans; Hyperthyroidism; Hypoglycemic Agents; L | 2020 |
Amiodarone-induced interstitial pneumonitis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Dyspnea; Humans; Lung Diseases, Inters | 2017 |
Acute amiodarone toxicity causing respiratory failure.
Topics: Aged; Amiodarone; Humans; Lung; Lung Diseases, Interstitial; Male; Pneumonia; Radiography, Thoracic; | 2017 |
Amiodarone Induced Interstitial and Organizing Pneumonia Reversed with Steroids.
Topics: Amiodarone; Anti-Arrhythmia Agents; Glucocorticoids; Humans; Lung Diseases, Interstitial; Male; Midd | 2017 |
Consensus statement for the diagnosis and treatment of drug-induced lung injuries.
Topics: Acute Lung Injury; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents; Antineoplastic Agents; | 2013 |
ECMO for pulmonary rescue in an adult with amiodarone-induced toxicity.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Extracorporeal Membrane Oxygenation; Humans; Lung; | 2015 |
Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?
Topics: Alveolitis, Extrinsic Allergic; Amiodarone; Arthritis, Rheumatoid; Diagnosis, Differential; Humans; | 2014 |
Diffuse alveolar damage in a patient receiving dronedarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biopsy; Diagnosis, Differential; Dron | 2015 |
[In Process Citation].
Topics: Aged; Amiodarone; Bronchoscopy; Dyspnea; Humans; Lung Diseases, Interstitial; Macrophages, Alveolar; | 2016 |
Obesity Is Associated With the Development of Interstitial Pneumonia Under Long-Term Administration of Amiodarone in Refractory Atrial Fibrillation Patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillati | 2016 |
Pathological autopsy of a patient that underwent a successful ablation of an electrical storm from the left ventricular summit.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Autopsy; Catheter Ablation; Electrocardiography; Electroph | 2016 |
Drug-induced interstitial pneumonia.
Topics: Amiodarone; Cytotoxins; Drug-Related Side Effects and Adverse Reactions; Humans; Imidazolidines; Lun | 2008 |
Amiodarone induced pneumonitis and hyperthyroidism: case report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnosis, Differential; Humans; Hyperthyro | 2008 |
Interstitial pneumonitis with accumulation of intraalveolar macrophages, a facet amiodarone therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Lung Diseases, Interstitial; Macrophages, Alveolar | 2008 |
Termination of recurrent ventricular tachycardia by continuous positive airway pressure ventilation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, H | 2009 |
[Drug-induced pulmonary interstitial disease].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents, Urinary; Biopsy; Bronchoscopy; Como | 2010 |
Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Fatal Outcome; Hemorrhage; Humans; Lung Di | 2010 |
Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure.
Topics: Acute Disease; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Femal | 2012 |
Population-level incidence and risk factors for pulmonary toxicity associated with amiodarone.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Femal | 2011 |
A 73-year-old man with interstitial lung disease due to dronedarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Humans; Lung; Lung Disea | 2012 |
Amiodarone-induced pulmonary toxicity--a fatal case report and literature review.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Drug Overdose; Fatal Outcome; Hal | 2013 |
SP-D as a marker of amiodarone-induced pulmonary toxicity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; Glucocorticoids; Glyco | 2002 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2003. An 82-year-old man with dyspnea and pulmonary abnormalities.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Blood Chemical Analysis; Bundle | 2003 |
Value of technetium-99m diethyltriamine pentaaceticacid radioaerosol inhalation lung scintigraphy for the stage of amiodarone-induced pulmonary toxicity.
Topics: Aerosols; Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Diagnosis, Differential | 2004 |
Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fine-needle aspiration: cytologic, histologic, and electronmicroscopic findings.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Biopsy, Fine-Needle; Chronic Disease; Cryptogenic Organizi | 2006 |
[Interstitial pneumonitis followed by syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy for dilated cardiomyopathy: a case report].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Humans; Inappropriat | 2006 |
[Clinicopathologic manifestation of amiodarone-induced lung injury].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Follow-Up Studies; Glucocorticoids; Humans; Lung; | 2006 |
Amiodarone pulmonary toxicity: a patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Body Mass Index; Cardiomyopathy | 2006 |
[Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports].
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Cardiomy | 2006 |
Clinical lessons from an elderly man with amiodarone-induced interstitial lung disease.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Asbestosis; Diagnostic Errors; Humans; Lung D | 2007 |
Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease.
Topics: Amiodarone; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductas | 2007 |
Amiodarone-induced lung disease.
Topics: Amiodarone; Diagnosis, Differential; Humans; Lung Diseases, Interstitial; Radiography, Thoracic; Tom | 2008 |
Amiodarone-induced pulmonary toxicity.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Lung Diseases, Intersti | 2008 |
[Interstitial pneumonitis in a patient treated with amiodarone -- case report].
Topics: Adrenal Cortex Hormones; Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Lung Diseases, Interstiti | 2008 |
[Computerized tomography aspects of amiodarone poisoning].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Dose-Response Relationship, Drug; Female | 1995 |
[Pneumopathy caused by amiodarone in internal medicine: 8 cases].
Topics: Aged; Aged, 80 and over; Amiodarone; Dyspnea; Female; Humans; Lung Diseases, Interstitial; Male; Ret | 1993 |
Primum non nocere. Is the therapy worse than the disease?
Topics: Amiodarone; Humans; Lung; Lung Diseases, Interstitial; Pneumonectomy; Postoperative Complications; P | 1994 |
Alveolar macrophage surface carbohydrate expression is altered in interstitial lung disease as determined by lectin-binding profiles.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Binding, Competitive; Bronchoalveolar Lavage | 1993 |
Amiodarone-associated hemoptysis.
Topics: Aged; Aged, 80 and over; Amiodarone; Hemoptysis; Humans; Lung; Lung Diseases, Interstitial; Male | 1994 |
Chronic amiodarone ingestion induces pulmonary toxicity in rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Lung; Lung Diseases, Interstitial; Male; Microscopy, El | 1996 |
Amiodarone as treatment for atrial tachycardias after surgery.
Topics: Administration, Oral; Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Cathete | 1997 |
[Spontaneous remission of an amiodarone-induced pulmonary lesion].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Lung Diseases, Interstitial; Radiog | 1997 |
[Amiodarone pulmonary toxicity: radiological coexistence of nodules with interstitial and alveolar abnormalities].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Lung Diseases, Interstitial; Radiography | 1998 |
Amiodarone-induced pulmonary toxicity in an adolescent.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Drug Therapy, Combinati | 1999 |
Near normalization of spirometry in a subject with severe emphysema complicated by amiodarone lung.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Emphysema; Forced Expiratory Volume; Humans; Lung Diseases | 1999 |
[Interstitial pneumopathy 2 months after discontinuing treatment with amiodarone].
Topics: Aged; Amiodarone; Humans; Long-Term Care; Lung Diseases, Interstitial; Male; Myocardial Ischemia; Su | 1999 |
KL-6 as a potential new marker for amiodarone-induced pulmonary toxicity.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; C-Reactive Prote | 2000 |
KL-6 as a serum marker for amiodarone-induced pulmonary toxicity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; Diagnosis, Differentia | 2000 |
Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; Carbon Monoxide; Cardi | 2000 |
[Diagnostic quiz. Increasing dyspnea after bypass operation. Interstitial lung disease].
Topics: Aged; Amiodarone; Coronary Artery Bypass; Humans; Lung Diseases, Interstitial; Male; Myocardial Infa | 2001 |
Amiodarone and cyclophosphamide: potential for enhanced lung toxicity.
Topics: Amiodarone; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Synergism; Drug-R | 2001 |
HRCT findings of amiodarone pulmonary toxicity: clinical and radiologic regression.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Respirat | 2001 |
Pathologic quiz case: pulmonary infiltrates with characteristic light and electron microscopic features.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Collagen Diseases; Diagnosis, Differentia | 2002 |